Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia (CLOVER-WaM)
An Open-Label, Multicenter, Phase 2 Study of Iopofosine I 131 (CLR 131) in Patients With Relapsed or Refractory (R/R) Select B-Cell Malignancies (CLOVER-1) and Expansion Cohort in Patients With Waldenstrom Macroglobulinemia (CLOVER-WaM)
Sponsor: Cellectar Biosciences, Inc.
A PHASE2 clinical study on Central Nervous System Lymphoma and Chronic Lymphocytic Leukemia, this trial is ongoing. The trial is conducted by Cellectar Biosciences, Inc. and has accumulated 29 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
29 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting PHASE2
-
Apr 2025 — Sep 2025 [monthly]
Active Not Recruiting PHASE2
-
Oct 2024 — Apr 2025 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2
▶ Show 24 earlier versions
-
Feb 2024 — Jul 2024 [monthly]
Recruiting PHASE2
-
Sep 2023 — Feb 2024 [monthly]
Recruiting PHASE2
-
Feb 2023 — Sep 2023 [monthly]
Recruiting PHASE2
-
Sep 2022 — Feb 2023 [monthly]
Recruiting PHASE2
-
Jun 2022 — Sep 2022 [monthly]
Recruiting PHASE2
-
Mar 2022 — Jun 2022 [monthly]
Recruiting PHASE2
-
Jan 2022 — Mar 2022 [monthly]
Recruiting PHASE2
-
Nov 2021 — Jan 2022 [monthly]
Recruiting PHASE2
-
Oct 2021 — Nov 2021 [monthly]
Recruiting PHASE2
-
Sep 2021 — Oct 2021 [monthly]
Recruiting PHASE2
-
Mar 2021 — Sep 2021 [monthly]
Recruiting PHASE2
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE2
-
Jul 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
May 2020 — Jul 2020 [monthly]
Recruiting PHASE2
-
Feb 2020 — May 2020 [monthly]
Recruiting PHASE2
-
Aug 2019 — Feb 2020 [monthly]
Recruiting PHASE2
-
Feb 2019 — Aug 2019 [monthly]
Recruiting PHASE2
-
Jun 2018 — Feb 2019 [monthly]
Recruiting PHASE2
-
Feb 2018 — Jun 2018 [monthly]
Recruiting PHASE2
-
Nov 2017 — Feb 2018 [monthly]
Recruiting PHASE2
-
Sep 2017 — Nov 2017 [monthly]
Recruiting PHASE2
-
Aug 2017 — Sep 2017 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Feb 2017 — Aug 2017 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Cellectar Biosciences, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .